We caught up with Dr. Richard Whitlock to discuss the BoxX-NoAF trial, studying if surgical ablation + LAAE during cardiac surgery can prevent new-onset post-op Afib in at-risk patients with no prior history.

Learn more: <a href="https://t.co/WrDP1tNO23&quot; target="_blank">https://t.co/WrDP1tNO23</a&gt;

<a href="https://twitter.com/hashtag/Afib?src=hashtag_click&quot; target="_blank">#Afib</a> <a href="https://twitter.com/hashtag/ClinicalTrial?src=hashtag_click&quot; target="_blank">#ClinicalTrial</a>

AtriClip represents two decades of continuous innovation in left atrial appendage exclusion solutions.

Discover why it’s the global choice: <a href="https://t.co/xxzH5phMpp&quot; target="_blank">https://t.co/xxzH5phMpp</a&gt;

<a href="https://twitter.com/hashtag/AtriClip?src=hashtag_click&quot; target="_blank">#AtriClip</a> <a href="https://twitter.com/hashtag/LAAExclusion?src=hashtag_click&quot; target="_blank">#LAAExclusion</a> <a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a>

Experience you can trust. Innovation that lasts.

The EnCompass clamp has been used in 30,000+ patients and is backed by 20+ years of surgical ablation innovation — refined to support consistent performance and reliable lesion formation in the OR.

Learn more:

Headed to <a href="https://twitter.com/hashtag/AATS2026?src=hashtag_click&quot; target="_blank">#AATS2026</a>? Stop by the AtriCure booth to get hands-on with the global leader in LAAE, the AtriClip device, and explore the Isolator® Synergy™ EnCompass® Clamp for surgical ablation. See you there!

AF and Heart Failure.​
​
Two conditions that are likely to dominate the next 50 years of cardiovascular care are also increasing in prevalence.​
​
Both affect millions of people and after age 40:​
​
1 in 4 people will develop AF​
1 in 5 people will develop HF​
​
And, regardless of which comes first - patients with AF and HF together have significantly worse prognosis. ​
​
Learn more about the impact of heart failure and AF: <a href="https://okt.to/ALk5Hv&quot; target="_blank">https://okt.to/ALk5Hv</a&gt; ​
​
<a href='https://www.linkedin.com/feed/hashtag/?keywords=HeartFailure&highlighte…; target='_blank'>#HeartFailure</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a>​

At <a href="https://twitter.com/hashtag/HRS2026?src=hashtag_click&quot; target="_blank">#HRS2026</a> we'll be connecting with surgeons as we share a durable treatment option for advanced Afib patients and discuss how to manage the left atrial appendage in minimally invasive cases with our latest innovation, the AtriClip PRO-Mini® device. We hope to see you there!

Facing an amputation can bring a lot of unknowns — including pain after surgery. Cryo Nerve Block is a pain management option used during surgery that temporarily stops pain signals at the nerve, helping support a more comfortable recovery.

Learn more and talk with your care team about whether it may be right for you: <a href="https://okt.to/Nzd6aA&quot; target="_blank">https://okt.to/Nzd6aA</a&gt; <a href="https://www.facebook.com/hashtag/

Amputation" target="_blank">

#Amputation</a>

For many thoracic patients, how pain is managed can define their recovery experience. Cryo Nerve Block offers surgeons a precise, non-opioid approach designed to redefine post-operative pain management for patients.​

Discover how: <a href="https://t.co/XOukS5tpKs&quot; target="_blank">https://t.co/XOukS5tpKs</a&gt;

<a href="https://twitter.com/hashtag/cryoNB?src=hashtag_click&quot; target="_blank">#cryoNB</a>

As a first-of-its-kind, the Isolator® Synergy™ Clamp devices helped define the standard for surgical ablation and remains the only FDA-approved surgical device for the treatment of atrial fibrillation during concomitant cardiac procedures.

Discover why: <a href="https://t.co/VnY3yQndov&quot; target="_blank">https://t.co/VnY3yQndov</a&gt;

Join us at <a href='https://www.linkedin.com/feed/hashtag/?keywords=EHRA2026&highlightedUpd…; target='_blank'>#EHRA2026</a> for a focused symposium on Hybrid AF™ Therapies for advanced atrial fibrillation. This session will explore epi-endocardial ablation strategies, long-term durability data, and patient selection, followed by an interactive panel discussion.

Learn more at: <a href="https://lnkd.in/eUXF_VA4&quot; target="_blank">https://lnkd.in/eUXF_VA4</a&gt;

<a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=LAAE&highlightedUpdateU…; target='_blank'>#LAAE</a>
European Society of Cardiology